Fresenius Medical Care AG & Co. (FMS)
(Delayed Data from NYSE)
$21.04 USD
+0.33 (1.59%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $21.05 +0.01 (0.05%) 5:24 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$21.04 USD
+0.33 (1.59%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $21.05 +0.01 (0.05%) 5:24 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Zacks News
CHDN, AMC, FMS, OMI and TMO as Zacks Bull and Bear of the Day
by Zacks Equity Research
CHDN, AMC, FMS, OMI and TMO as Zacks Bull and Bear of the Day
3 MedTech Outperformers to Grab Amid Coronavirus Pandemic
by Trina Mukherjee
Let's grab these three stocks that have shown tremendous promise amid the coronavirus pandemic.
The Zacks Analyst Blog Highlights: TVTY, NXGN, ELMD and FMS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: TVTY, NXGN, ELMD and FMS
Should Value Investors Buy Fresenius (FMS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FMS or SMLR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
FMS vs. SMLR: Which Stock Is the Better Value Option?
4 MedTech Growth Stocks With Strong ROE to Buy Amid Coronavirus
by Debanjana Dey
Here are some MedTech growth stocks which might be solid investment options for profit-maximization amid the coronavirus-led market mayhem.
5 Best GARP Stocks Based on Discounted PEG
by Urmimala Biswas
There are some drawbacks to using the PEG ratio though. It does not consider the very common situation of changing growth rates.
Here's Why You Should Invest in Fresenius Medical Stock Now
by Zacks Equity Research
Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services.
Is Fresenius (FMS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FMS or SMLR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
FMS vs. SMLR: Which Stock Is the Better Value Option?
3 Reasons Why Fresenius (FMS) Is a Great Growth Stock
by Zacks Equity Research
Fresenius (FMS) could produce exceptional returns because of its solid growth attributes.
New Strong Buy Stocks For August 18th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Is Fresenius (FMS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FMS vs. SMLR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FMS vs. SMLR: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: Smurfit Kappa, Turning Point Brands, Griffon and Fresenius Medical Care
by Zacks Equity Research
Zacks.com featured highlights include: Smurfit Kappa, Turning Point Brands, Griffon and Fresenius Medical Care
Forget Profit, Bet on These 4 Stocks With Rising Cash Flows
by Moumita C. Chattopadhyay
Even though profit is a company's goal, cash is its lifeblood for existence and a measure of resiliency.
Fresenius Medical (FMS) Q2 Earnings & Revenues Top Estimates
by Zacks Equity Research
Fresenius Medical's (FMS) second-quarter earnings benefit from strong segmental performance.
Looking for a Growth Stock? 3 Reasons Why Fresenius (FMS) is a Solid Choice
by Zacks Equity Research
Fresenius (FMS) could produce exceptional returns because of its solid growth attributes.
Idexx (IDXX) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Idexx (IDXX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
New Strong Buy Stocks For August 3rd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Should Value Investors Buy Fresenius (FMS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FMS vs. ABMD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FMS vs. ABMD: Which Stock Is the Better Value Option?
Fresenius Medical (FMS) Q1 Earnings Miss Estimates, Fall Y/Y
by Zacks Equity Research
Fresenius Medical's (FMS) first-quarter earnings benefit from strong segmental performance.
Is Fresenius (FMS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Analyst Blog Highlights: PayPal, International Business Machines, Fresenius Medical Care, Laboratory Corp. of America and Insulet
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PayPal, International Business Machines, Fresenius Medical Care, Laboratory Corp. of America and Insulet